Fish Oil Triglycerides
- TRADE NAME: Omegaven (Fresenius Kabi USA)
- INDICATIONS: indicated as a source of calories and fatty acids in pediatric patients with parenteral nutrition-associated cholestasis
FDA APPROVAL DATE: 07/27/2018
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:None known
PREGNANCY CATEGORY: N/A
no available data
Risk of Death in Preterm Infants due to Pulmonary Lipid Accumulation; Hypersensitivity Reactions; Risk of Infections, Fat Overload Syndrome, Refeeding Syndrome, and Hypertriglyceridemia; Aluminum Toxicity
See full prescribing information for complete boxed warning
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric